Protein Levels Could Replace Genetic Tests for Detecting ARID1A Mutations

Protein Levels Could Replace Genetic Tests for Detecting ARID1A Mutations
A laboratory technique that measures protein levels in tissue samples — called immunohistochemistry (IHC) — is a quicker and less expensive alternative to detect ARID1A mutations in patients with ovarian  and other gynecological cancers, a new study shows. As more treatments are being tested for patients with ARID1A mutations, the approach may allow patients to be classified more

Knowledge is power when living with ovarian cancer.

Get access to the web’s leading Ovarian Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *